Jonathan Sheena - Jul 22, 2021 Form 4 Insider Report for Natera, Inc. (NTRA)

Role: Director, CO-FOUNDER
Signature: /s/ Tami Chen, Attorney-in-Fact
Stock symbol: NTRA
Transactions as of: Jul 22, 2021
Transactions value $: -$152,403
Form type: 4
Date filed: 7/26/2021, 06:07 PM
Previous filing: Jul 13, 2021
Next filing: Sep 1, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NTRA	Common Stock	Options Exercise	$1.01K	+187	+0.04%	$5.40^*	456K	Jul 22, 2021	Direct
transaction	NTRA	Common Stock	Options Exercise	$623	+65	+0.01%	$9.59^*	456K	Jul 22, 2021	Direct
transaction	NTRA	Common Stock	Options Exercise	$4.16K	+400	+0.09%	$10.41^*	456K	Jul 22, 2021	Direct
transaction	NTRA	Common Stock	Options Exercise	$6.5K	+700	+0.15%	$9.29^*	457K	Jul 22, 2021	Direct
transaction	NTRA	Common Stock	Sale	-$108K	-887	-0.19%	$121.36	456K	Jul 22, 2021	Direct	F1, F2
transaction	NTRA	Common Stock	Sale	-$36.7K	-300	-0.07%	$122.36	456K	Jul 22, 2021	Direct	F1, F3
transaction	NTRA	Common Stock	Sale	-$20.3K	-165	-0.04%	$123.31	456K	Jul 22, 2021	Direct	F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NTRA	Stock Option (right to buy)	Options Exercise	$0	-187	-12.34%	$0.00	1.33K	Jul 22, 2021	Common Stock	187	$5.40	Direct	F5
transaction	NTRA	Stock Option (right to buy)	Options Exercise	$0	-65	-0.16%	$0.00	40.3K	Jul 22, 2021	Common Stock	65	$9.59	Direct	F6
transaction	NTRA	Stock Option (right to buy)	Options Exercise	$0	-400	-1.12%	$0.00	35.3K	Jul 22, 2021	Common Stock	400	$10.41	Direct	F7
transaction	NTRA	Stock Option (right to buy)	Options Exercise	$0	-700	-3.88%	$0.00	17.3K	Jul 22, 2021	Common Stock	700	$9.29	Direct	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.15 to $122.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.19 to $123.52 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5	The option shares vested fully and became exercisable on November 20, 2019.
F6	The option shares vested fully and became exercisable on April 1, 2020.
F7	The option shares vested fully and became exercisable on March 21, 2021.
F8	The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.